| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | 1 |
| 1 | ALEMTUZUMAB | 1 |
| 2 | CLOFARABINE | 1 |
| 3 | DALTEPARIN SODIUM | 1 |
| 4 | LAROTRECTINIB | 1 |
| 5 | MELPHALAN | 1 |
| 6 | MELPHALAN HYDROCHLORIDE | 1 |
| 7 | MONTELUKAST SODIUM | 1 |
| 8 | WARFARIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAROTRECTINIB | 1 | 0.0011 |
| 1 | ACETAMINOPHEN AND CHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 2 | CLOFARABINE | 1 | 0.0004 |
| 3 | DALTEPARIN SODIUM | 1 | 0.0001 |
| 4 | ALEMTUZUMAB | 1 | 0.0001 |
| 5 | MELPHALAN HYDROCHLORIDE | 1 | 0.0000 |
| 6 | MONTELUKAST SODIUM | 1 | 0.0000 |
| 7 | WARFARIN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 1 |
| 1 | Kinase Inhibitor [EPC] | 1 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Kinase Inhibitor [EPC] | 1 | 0.0000 |